AMASSE CAPITAL (08168): Chen Zengwu and Wu Jiaqi Appointed as Independent Non-Executive Directors

date
22:45 16/10/2026
avatar
GMT Eight
Amasse Capital (08168) announced that, in order to take up the position of company secretary of the Company, Mr. Tang Yiu Kei (Mr. Tang) has resigned as an independent non-executive director of the Company, the chairman of the audit committee and the independent investigation committee, and a member of the remuneration committee and the nomination committee, with effect from 16 October 2026.
AMASSE CAPITAL (08168) announces that, in order to assume the role of company secretary of the Company, Mr. Tang Yiu Kei (Mr. Tang) has resigned as an independent non-executive Director of the Company, the chairman of the audit committee and the independent investigation committee, and a member of the remuneration committee and the nomination committee, with effect from 16 October 2026. The Company has entered into a corporate secretarial support services agreement with Pui Sze Corporate Services Limited, pursuant to which Pui Sze Corporate Services Limited has agreed to provide corporate secretarial services to the Company. Mr. Tang is a director of Pui Sze Corporate Services Limited. He has been assigned by Pui Sze Corporate Services Limited and appointed by the Company as (i) the company secretary of the Company; and (ii) the authorized representative of the Company under Rule 5.24 of the GEM Listing Rules, with effect from 16 October 2026. The Board has appointed Mr. Chen Zengwu (Mr. Chen) and Mr. Wu Jiaqi (Mr. Wu) as independent non-executive Directors, with effect from 16 October 2026. With effect from 16 October 2026, (1) Mr. Tang ceased to be the chairman of the audit committee and a member of each of the remuneration committee and the nomination committee; (2) Mr. Chen has been appointed as the chairman of the audit committee and a member of each of the remuneration committee and the nomination committee; (3) Mr. Wu has been appointed as a member of each of the audit committee, the remuneration committee and the nomination committee; and (4) Ms. Jiang Dandan, an executive Director, has been appointed as a member of the nomination committee. Following the resignation of Mr. Tang and the appointment of Mr. Chen and Mr. Wu: (1) Mr. Tang ceased to be the chairman of the investigation committee; (2) Mr. Chen has been appointed as the chairman of the investigation committee; and (3) Mr. Wu has been appointed as a member of the investigation committee.